Search
Cronos Group Inc
CRONAdd to Watchlist
2.810USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
1.06BMarket Cap
LossP/E TTM
More Details of Cronos Group Inc Company
Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Cronos Group Inc Info
Ticker SymbolCRON
Company nameCronos Group Inc
IPO dateMay 07, 2014
CEOGorenstein (Michael Ryan)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMay 07
Address4491 Concession Rd 12
CityTORONTO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeL0M 1S0
Phone14165040004
Websitehttps://thecronosgroup.com/
Ticker SymbolCRON
IPO dateMay 07, 2014
CEOGorenstein (Michael Ryan)
Company Executives of Cronos Group Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.21M
+4.56%
Mr. Jason Marc Adler
Mr. Jason Marc Adler
Independent Director
Independent Director
9.88M
--
Mr. Jeffrey David (Jeff) Jacobson
Mr. Jeffrey David (Jeff) Jacobson
Chief Growth Officer
Chief Growth Officer
484.68K
+3.64%
Ms. Anna Shlimak
Ms. Anna Shlimak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
358.60K
+29.12%
Ms. Shannon Buggy
Ms. Shannon Buggy
Senior Vice President, Global Head of People
Senior Vice President, Global Head of People
178.32K
+6.42%
Mr. James (Jim) Rudyk
Mr. James (Jim) Rudyk
Lead Independent Director
Lead Independent Director
--
--
Mr. Murray R. Garnick, J.D.
Mr. Murray R. Garnick, J.D.
Independent Director
Independent Director
--
--
Mr. Terry Doucet
Mr. Terry Doucet
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Mr. Arye Weigensberg
Mr. Arye Weigensberg
Senior Vice President, Head of Research & Development
Senior Vice President, Head of Research & Development
--
--
Mr. Kamran Khan
Mr. Kamran Khan
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Mr. Michael Ryan (Mike) Gorenstein, J.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
13.21M
+4.56%
Mr. Jason Marc Adler
Mr. Jason Marc Adler
Independent Director
Independent Director
9.88M
--
Mr. Jeffrey David (Jeff) Jacobson
Mr. Jeffrey David (Jeff) Jacobson
Chief Growth Officer
Chief Growth Officer
484.68K
+3.64%
Ms. Anna Shlimak
Ms. Anna Shlimak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
358.60K
+29.12%
Ms. Shannon Buggy
Ms. Shannon Buggy
Senior Vice President, Global Head of People
Senior Vice President, Global Head of People
178.32K
+6.42%
Mr. James (Jim) Rudyk
Mr. James (Jim) Rudyk
Lead Independent Director
Lead Independent Director
--
--
FAQs
Who are the top five shareholders of Cronos Group Inc?
The top five shareholders of Cronos Group Inc are: Mr. Michael Ryan (Mike) Gorenstein, J.D.
How many institutions hold shares of Cronos Group Inc (CRON)?
As of 2026Q1, 377 institutions hold shares of Cronos Group Inc, with a combined market value of approximately 61.74M, accounting for 16.41% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -12850118.00.
What is the biggest source of revenue for Cronos Group Inc?
In 2026Q1, the Cannabis Flower business generated the highest revenue for Cronos Group Inc, amounting to 108.48M and accounting for 74.00% of total revenue.
